Answers are grounded in this paper and cite their sources.
Review demonstrates effective pain relief using intrathecal morphine in patients with chronic malignant pain, suggesting improved quality of life.
Chronic malignant pain is a common and feared condition. Especially, since many patients do not achieve proper pain relief from conventional peroral medication regimes and possible unacceptable side effects of high dosing. As argued in this review, in these patients, continuous intrathecal infusion of pain medicine by a programmable subcutaneously placed pump enables good pain relief, less systemic side effects, and better life quality. Intrathecal pain treatment should therefore be considered in patients with a proper performance score and suitable estimated life expectancy.
No takes yet. Share an insight, caveat, or question.
Miscov et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: